IONS Q4 2018 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$12B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$192M+11.5% YoY

Gross Profit

$77M40.0% margin

Operating Income

$11M5.6% margin

Net Income

$320M166.6% margin

EPS (Diluted)

$2.21

QoQ Revenue Growth

+32.1%

Cash Flow

Operating Cash Flow

$115M

Free Cash Flow

$113M

Stock-Based Comp.

$34M

Balance Sheet

Total Assets

$2.7B

Total Liabilities

$1.5B

Stockholders' Equity

$1.0B

Cash & Equivalents

$279M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$192M	$172M	+11.5%
Gross Profit	$77M	$44M	+74.6%
Operating Income	$11M	-$2M	+737.0%
Net Income	$320M	$3M	+11556.1%